Increased β‐site APP cleaving enzyme 1‐mediated insulin receptor cleavage in type 2 diabetes mellitus with cognitive impairment

Autor: Hong Bao, Yong Shen, Mengguo Zhang, Feng Gao, Weiwei Zhang, Dongmei Kang, Yuhao Ge, Zuolong Chen, Yiming Liu
Rok vydání: 2021
Předmět:
Male
0301 basic medicine
medicine.medical_specialty
Epidemiology
Mutant
Disease
Cohort Studies
Amyloid beta-Protein Precursor
03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
Insulin resistance
Developmental Neuroscience
Alzheimer Disease
Internal medicine
mental disorders
Amyloid precursor protein
Aspartic Acid Endopeptidases
Humans
Medicine
Cognitive Dysfunction
Aged
Glycemic
chemistry.chemical_classification
biology
business.industry
Health Policy
nutritional and metabolic diseases
Type 2 Diabetes Mellitus
Middle Aged
medicine.disease
Receptor
Insulin

Psychiatry and Mental health
Insulin receptor
030104 developmental biology
Endocrinology
Enzyme
Diabetes Mellitus
Type 2

chemistry
biology.protein
Female
Neurology (clinical)
Amyloid Precursor Protein Secretases
Geriatrics and Gerontology
business
030217 neurology & neurosurgery
Zdroj: Alzheimer's & Dementia. 17:1097-1108
ISSN: 1552-5279
1552-5260
Popis: Introduction Patients with type 2 diabetes mellitus (T2DM) are at a high risk of cognitive impairment, with insulin resistance playing a pivotal role. β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is considered a predictor of Alzheimer's disease. However, the potential roles of BACE1 in insulin resistance and the risk of cognitive impairment in T2DM remain unclear. Methods We measured plasma BACE1 levels, BACE1 cleavage activities for Swedish mutant amyloid precursor protein (APPsw) and insulin receptor β subunit (INSR-β), and soluble INSR (sINSR) levels in a clinical cohort study. Results T2DM patients with or without cognitive impairment exhibited elevated plasma BACE1 levels and BACE1 enzymatic activities for APPsw and INSR-β, and sINSR levels. Moreover, the glycemic status correlated with elevated BACE1 levels and BACE1-mediated INSR cleavage, which was associated with insulin resistance. Discussion The elevated BACE1 levels in T2DM may contribute to increasing the cognitive impairment risk through both amyloidogenesis and insulin resistance.
Databáze: OpenAIRE